Innovita Biological Technology Co., Ltd. (SHA:688253)

SHA:688253 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue Revenue Growth	323.87	422.03	621.39	478.02	446.62	326.91
Revenue Growth	-40.76%	-32.08%	29.99%	7.03%	36.62%	-68.48%
Gross Profit Gross Profit Growth	237	325.94	493.86	337.51	272.67	249.67
Operating Income Operating Income Growth	68.39	130.49	240.03	178.94	94.59	132.09
Net Income Net Income Growth	89.82	144.47	246.86	173.95	150.68	120.25
Earnings Per Share EPS Growth	0.66	1.06	1.81	1.28	1.24	1.18
EPS Growth	-54.14%	-41.44%	41.41%	3.23%	5.08%	-79.55%

Revenue by Geography

Chart

Fiscal Year	FY 2025
Period Ending	Dec 31, 2025
East China East China Growth	123.74
Northwest China Northwest China Growth	34.61
North China North China Growth	64.6
Central China Central China Growth	37.86
Southwest China Southwest China Growth	71.07
Northeast China Northeast China Growth	24.89
South China South China Growth	53.43
Overseas (including Hong Kong, Macao and Taiwan) Overseas (including Hong Kong, Macao and Taiwan) Growth	11.82
Total Total Growth	422.03

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Investments Cash & Investments Growth	1,894	1,949	1,892	1,697	1,503	566.99
Total Debt Total Debt Growth	9.34	7.78	5.77	3	23.12	1.4
Net Cash (Debt) Net Cash Growth	1,884	1,942	1,886	1,694	1,480	565.59
Net Cash Growth	-4.49%	2.93%	11.35%	14.45%	161.71%	-3.73%
Net Cash Per Share Net Cash Per Share Growth	13.84	14.25	13.83	12.47	12.18	5.55

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating Cash Flow Operating Cash Flow Growth	48.49	193.13	305.46	259.85	126.43	106.27
Capital Expenditures CapEx Growth	-24.66	-31.13	-36.16	-16.97	-57.71	-63.75
Free Cash Flow Free Cash Flow Growth	23.82	162	269.31	242.89	68.71	42.52
Free Cash Flow Growth	-90.92%	-39.84%	10.88%	253.47%	61.59%	-92.45%

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Gross Margin	73.18%	77.23%	79.48%	70.60%	61.05%	76.37%
Operating Margin	21.12%	30.92%	38.63%	37.43%	21.18%	40.41%
Pretax Margin	29.01%	37.83%	44.50%	41.50%	36.83%	42.15%
Profit Margin	27.73%	34.23%	39.73%	36.39%	33.74%	36.79%
FCF Margin	7.36%	38.39%	43.34%	50.81%	15.38%	13.01%

Dividends

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 4, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Dividend Per Share Dividend Per Share Growth	0.450	0.450	0.560	0.400	0.166
Dividend Per Share Growth	-19.64%	-19.64%	40.00%	140.96%	-
Dividend Yield	0.81%	1.50%	1.58%	1.66%	0.73%

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 4, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	84.92	28.17	20.04	19.56	21.51	-
Forward PE	60.25	24.74	9.91	-	-	-
P/FCF Ratio	317.21	25.13	18.37	14.01	47.17	-
PS Ratio	23.33	9.65	7.96	7.12	7.26	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 31, 2026

Data Sources Report a data error